International team identifies genetic model for predicting primary myelofibrosis outcomes

(Mayo Clinic) A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease. The group's findings were presented today at the 59th American Society of Hematology annual meeting in Atlanta by lead authors Alessandro Vannucchi, M.D., from the University of Florence and Ayalew Tefferi, M.D., a hematologist at Mayo Clinic.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news